PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Health Policy Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.\', \'Shanghai Bluecross Medical Science Institute, Shanghai.\', \'Institute for Hospital Management, Tsing Hua University, Shenzhen Campus.\', \'Tai Kang Institute of Healthcare Management, Beijing.\', \'Department of Medical Research and Education, Cheng-Hsin General Hospital, Taipei, Taiwan.\', \'Maoming People\'s Hospital, Maoming, Guangdong, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000024650
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 33578592
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
?:title
  • Insights from the comparisons of SARS-CoV and COVID-19 outbreaks: The evidence-based experience of epidemic prevention in China.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all